Open Access

VIEWPOINT

Resveratrol-related compounds: Potential for cancer and beyond

by MONICA SAVIO, VALENTINA MINOIA, PAOLA FULGHIERI, LUCIA ANNA STIVALA^*, VIRGINIE SOTTILE^*

Department of Molecular Medicine, University of Pavia, Pavia, 27100, Italy

* Corresponding Authors: LUCIA ANNA STIVALA. Email: ; VIRGINIE SOTTILE. Email:

BIOCELL 2022, 46(12), 2525-2530. https://doi.org/10.32604/biocell.2022.022924

Received 31 March 2022; Accepted 24 May 2022; Issue published 10 August 2022

Abstract

The nutraceutical resveratrol is associated with a range of biological effects, from antibiotic to anti-inflammatory activities. One major axis of research has sought to harness its anti-tumour potential, with promising preclinical results and early clinical trials. A second strong interest relies on the anti-ageing effects ascribed to the compound and its application to stem cell research. It is becoming clear however that these possible favourable effects are conditioned by a set concentration range not easily controllable in vivo. Here we evoke novel developments in the field that could lead to more reliable conditions for the translational use of resveratrol-based compounds.

---

Keywords

---